ONCOLYTICS BIOTECH INC

What the company reported for its principal executive officer, usually the CEO, in the pay-versus-performance table of its proxy statement. The total counts shares and options at their value on the day they were granted. Actually paid counts them at the change in their value during the year, so it can be far higher or lower than the total, and negative. A dash means the company reported no amount.

Kelly, fiscal year ended Dec 31, 2025: total $2,108,512, actually paid $6,036,332. First reported Oct 6, 2026.

Pisano, fiscal year ended Dec 31, 2025: total $433,141, actually paid $464,739. First reported Oct 6, 2026.

Earlier fiscal years are part of the subscription.